{"id":"https://openalex.org/W3035002194","doi":"https://doi.org/10.1007/s10637-020-00963-w","title":"Safety and efficacy of afatinib for the treatment of non-small-cell lung cancer following osimertinib-induced interstitial lung disease: A retrospective study","display_name":"Safety and efficacy of afatinib for the treatment of non-small-cell lung cancer following osimertinib-induced interstitial lung disease: A retrospective study","publication_year":2020,"publication_date":"2020-06-15","ids":{"openalex":"https://openalex.org/W3035002194","doi":"https://doi.org/10.1007/s10637-020-00963-w","mag":"3035002194","pmid":"https://pubmed.ncbi.nlm.nih.gov/32542461"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-020-00963-w","doi":"https://doi.org/10.1007/s10637-020-00963-w","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-020-00963-w","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003936439","display_name":"Shingo Nasu","orcid":"https://orcid.org/0000-0003-1965-850X","observed_orcids":["https://orcid.org/0000-0003-1965-850X"]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shingo Nasu","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan. hugurahoma@yahoo.co.jp","Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1965-850X","affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan. hugurahoma@yahoo.co.jp","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]},{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101794776","display_name":"Hidekazu Suzuki","orcid":"https://orcid.org/0000-0002-8994-6163","observed_orcids":["https://orcid.org/0000-0002-8994-6163"]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidekazu Suzuki","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091673730","display_name":"Takayuki Shiroyama","orcid":"https://orcid.org/0000-0002-2816-9428","observed_orcids":["https://orcid.org/0000-0002-2816-9428"]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takayuki Shiroyama","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035744584","display_name":"Ayako Tanaka","orcid":"https://orcid.org/0009-0009-1915-1400","observed_orcids":["https://orcid.org/0009-0009-1915-1400"]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ayako Tanaka","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010456173","display_name":"Yumiko Samejima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yumiko Samejima","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068499239","display_name":"Tomohiro Kanai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomohiro Kanai","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073782290","display_name":"Yoshimi Noda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshimi Noda","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041146732","display_name":"Naoko Morishita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoko Morishita","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111206254","display_name":"Norio Okamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norio Okamoto","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108254232","display_name":"Tomonori Hirashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282797","display_name":"Osaka Prefectural Hospital Organization","ror":"https://ror.org/00fb90w44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282797"]},{"id":"https://openalex.org/I4405284727","display_name":"Osaka Habikino Medical Center","ror":"https://ror.org/0443v4r38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284727"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomonori Hirashima","raw_affiliation_strings":["Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka Habikino Medical Center, 3-7-1 Habikino, Habikino City, Osaka, 583- 8588, Japan","institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003936439"],"corresponding_institution_ids":["https://openalex.org/I4405282797","https://openalex.org/I4405284727"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":null,"fwci":0.6953,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.72185214,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"38","issue":"6","first_page":"1915","last_page":"1920"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.9390000104904175},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.9179999828338623},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.9110000133514404},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/drug-induced-lung-injury","display_name":"drug-induced lung injury","score":0.6690000295639038},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.6200000047683716},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6769999861717224},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.9849128723144531},{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.979805588722229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8613021373748779},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7985013723373413},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.7705973386764526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5829694271087646},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5651131272315979},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.41929054260253906},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.33278119564056396},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3263700008392334},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28398749232292175},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.15468761324882507}],"mesh":[{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017563","descriptor_name":"Lung Diseases, Interstitial","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10637-020-00963-w","doi":"https://doi.org/10.1007/s10637-020-00963-w","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-020-00963-w","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:32542461","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32542461","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1574226582","https://openalex.org/W2111191667","https://openalex.org/W2134317440","https://openalex.org/W2147325425","https://openalex.org/W2161955176","https://openalex.org/W2165803850","https://openalex.org/W2268267848","https://openalex.org/W2517842615","https://openalex.org/W2519391460","https://openalex.org/W2560717039","https://openalex.org/W2587420003","https://openalex.org/W2607113889","https://openalex.org/W2733145356","https://openalex.org/W2762206132","https://openalex.org/W2770828094","https://openalex.org/W2772985786","https://openalex.org/W2803709151","https://openalex.org/W2903043657","https://openalex.org/W2922107046","https://openalex.org/W2933725736","https://openalex.org/W2990041408","https://openalex.org/W2990566344"],"related_works":["https://openalex.org/W3091266070","https://openalex.org/W3177017317","https://openalex.org/W4413407965","https://openalex.org/W4402003775","https://openalex.org/W3217401546","https://openalex.org/W4200486286","https://openalex.org/W4379280679","https://openalex.org/W4205369040","https://openalex.org/W4313521975","https://openalex.org/W3087540921"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-06-19T00:00:00"}